Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tizanidine for Postoperative Knee Pain After Total Knee Arthroplasty
ChiCTR2400091102Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in knee osteoarthritis (OA) comparing Tizanidine hydrochloride group with Placebo control group (2 arms). Primary endpoint: Postoperative pain score. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
tizanidine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2400091102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091102.